Papers on acarbose + glibenclamide
16 papers
Tuesday, May 31
Saturday, May 31
Diabetology & Metabolic Syndrome
Post-meal β-cell function predicts the efficacy of glycemic control in patients with type 2 diabetes inadequately controlled by metformin monotherapy after addition of glibenclamide or acarbose
Randomized trial in 51 peopleAcarbose
Thursday, November 10
Wednesday, January 1
Diabetes, Obesity & Metabolism
Influence of treatment with acarbose or glibenclamide on insulin sensitivity in type 2 diabetic patients
Randomized trial in 77 peopleAcarbose
Saturday, June 1
Diabetes, Nutrition & Metabolism
The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia
Randomized trial in 84 peopleAcarbose
Friday, March 1
Clinical Science
Vascular K(ATP) channel blockade by glibenclamide, but not by acarbose, in patients with Type II diabetes
Randomized trial in 12 peopleType 2 diabetes
Diabetes Research and Clinical Practice
Different effects of acarbose and glibenclamide on proinsulin and insulin profiles in people with Type 2 diabetes
Randomized trial in 27 peopleAcarbose
Monday, May 1
JPMA The Journal of the Pakistan Medical Association
Effect of acarbose on glycemic control, serum lipids and lipoproteins in type 2 diabetes
Non-randomized trial in 44 peopleAcarbose
Wednesday, April 1
Wednesday, October 1
Diabetes Research and Clinical Practice
Acarbose in ambulatory treatment of non-insulin-dependent diabetes mellitus associated to imminent sulfonylurea failure: a randomised-multicentric trial in primary health-care. Diabetes and Acarbose Research Group
Randomized trial in 65 peopleAcarbose
Monday, September 1
Diabetes Care
Glibenclamide, but not acarbose, increases leptin concentrations parallel to changes in insulin in subjects with NIDDM
Randomized trial in 6 peopleAcarbose
Monday, January 1
Biomedicine & Pharmacotherapy
Effect of acarbose on blood glucose profiles and plasma 1,5-anhydro-d-glucitol in type 2 diabetes poorly controlled by sulfonylurea therapy
Non-randomized trial in 16 peopleAcarbose
Tuesday, August 1
Clinical and Investigative Medicine Medecine Clinique et Experimentale
The use of acarbose in the primary-care setting: evaluation of efficacy and tolerability of acarbose by postmarketing surveillance study
Non-randomized trial in 10,462 peopleAcarbose
Wednesday, June 1
Diabetes Care
Efficacy of 24-week monotherapy with acarbose, glibenclamide, or placebo in NIDDM patients. The Essen Study
Randomized trial in 96 peopleAcarbose
Wednesday, January 1
Hormone and Metabolic Research Supplement Series
Efficacy of 6 months monotherapy with glucosidase inhibitor Acarbose versus sulphonylurea glibenclamide on metabolic control of dietary treated type II diabetics (NIDDM)
Randomized trial in peopleAcarbose
Tuesday, January 1
Deutsche Zeitschrift Fur Verdauungs- und Stoffwechselkrankheiten
Effect of acarbose on carbohydrate and lipid metabolism in type II diabetes with secondary failure
Randomized trial in 9 peopleAcarbose